Editorial

DOI: 10.4244/EIJ-E-24-00029

Role of leaflet modification in TAVI: to prevent coronary obstruction only or potentially a routine practice?

Toby Rogers1,2, MD, PhD; Lior Lupu1, MD, MBA

Over the years, transcatheter aortic valve implantation (TAVI) has been increasingly offered to younger patients. The trend has been driven not only by technological advancement and rigorous clinical trials but also by patient demand for interventions that are less invasive, with lower risk and faster recovery. This is evidenced by the high proportion of patients under the age of 65 who undergo TAVI in the USA despite the guidelines recommending surgical aortic valve replacement (SAVR) in this age group1. Younger patients who undergo TAVI are more likely to require reintervention for bioprosthetic valve failure (BVF). If BVF occurs, treatment options are limited to surgical explant or a second TAVI inside the failed valve (redo-TAVI). Both treatment options carry risks. Explant surgery is associated with high mortality rates (with recent data showing a 30-day mortality rate of 16%2). Redo-TAVI risks coronary obstruction and makes future coronary access more challenging345. This is because when we perform redo-TAVI and deploy a transcatheter heart valve (THV) inside a failed THV, we push the degenerated leaflets of the first valve...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 12
Jun 17, 2024
Volume 20 Number 12
View full issue


Key metrics

Suggested by Cory
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved